January 6, 2017 / 6:23 AM / 9 months ago

BRIEF-Ionis, Akcea enter into strategic collaboration with Novartis

Jan 6 (Reuters) - Ionis Pharmaceuticals Inc :

* Ionis and Akcea enter into strategic collaboration with global pharmaceutical company to develop and commercialize akcea-apo(a)-l rx and akcea-apociii-l rx

* Ionis Pharmaceuticals - Ionis and Akcea are eligible to receive tiered royalties in mid-teens to low twenty percent range on net sales of each drug

* Ionis Pharmaceuticals - Ionis, Akcea eligible to receive license fee as well as development, commercial milestone payments as each drug advances Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below